Financhill
Back

Ionis Pharmaceuticals Quote, Financials, Valuation and Earnings

Buy
62

IONS
Ionis Pharmaceuticals

Last Price:
41.85
Seasonality Move:
9.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Ionis Pharmaceuticals Price Quote

$41.85
+0.01 (+2.55%)
(Updated: June 22, 2024 at 5:40 AM ET)

Ionis Pharmaceuticals Key Stats

Buy
62
Ionis Pharmaceuticals (IONS) is a Buy

Day range:
$40.83 - $42.13
52-week range:
$35.95 - $54.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.75
P/B ratio:
20.6%

Volume:
962.9K
Avg. volume:
1.1M
1-year change:
1.38%
Market cap:
$6.1B
Revenue:
$787.6M
EPS:
$-2.67

How Much Does Ionis Pharmaceuticals Make?

Is Ionis Pharmaceuticals Growing As A Company?

  • What Is Ionis Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.08%
  • What Is Ionis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ionis Pharmaceuticals Stock Price Performance

What Is Ionis Pharmaceuticals 52-Week High & Low?

Ionis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ionis Pharmaceuticals?

Is Ionis Pharmaceuticals Cash Flow Positive?

  • What Is IONS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$323.5M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $175.6M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $187.6M

Ionis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    IONS return on invested capital is -23.32%
  • What Is Ionis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -13.23%
  • What Is IONS Return On Equity?
    ROE is a measure of profitability and is -100.54%

Ionis Pharmaceuticals Earnings Date & Stock Price

Ionis Pharmaceuticals Competitors

Ionis Pharmaceuticals Dividend Yield

Data Unavailable

Ionis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.3%
Revenue: -8.45% -12.76%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 58.04
Upside from Last Price: 38.71%

Major Shareholders

  • How many IONS shares are owned by institutional investors?
    243.1M IONS shares are owned by institutional investors
  • How many IONS shares are owned by insiders?
    1.4M IONS shares are owned by insiders